HER2 Support Group Forums - More evidence carbs fuel cancer

Following on from Rich post on the plant extract BZL101 Scutellaria barbata D. Don that seems to disrupt glycogenesis in Breast cancer cell. Bellow are the results, not bad 50% response rate for 3 months and some for longer. From the methodology it appears that it is just the plant extract ( I do not see their (financial) angle ..). but that is good.

Bezielle is an oral botanical drug designed for the treatment of breast cancer that targets only cancer cells but leaves normal cells intact and functioning.
Bionovo, Inc completed a preliminary trial to determine the side effects from Bezielle treatment and to determine if Bezielle is effective in the treatment of metastatic breast cancer .

Results of the preliminary trial:

- 21 women with metastatic breast cancer enrolled.
- On average, the group of women enrolled to the trial had been on 4 prior treatments for metastatic disease prior to starting Bezielle therapy.
- 16 women on the trial were evaluable for response:
  - 4 women had stable disease >90 days
  - 3 women had stable disease for >180 days
  - 1 woman was 1 mm short of a partial remission

http://www.bzl101.com/#summary